Prospective Multicenter Evaluation of [11C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing Disease.

Saved in:
Bibliographic Details
Title: Prospective Multicenter Evaluation of [11C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing Disease.
Authors: Flaus A; Nuclear Medicine Department, Hospices Civils de Lyon, Lyon, France; anthime.flaus@chu-lyon.fr.; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM, U1028, Université Claude Bernard Lyon 1, Lyon, France., Levigoureux E; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM, U1028, Université Claude Bernard Lyon 1, Lyon, France.; Radiopharmacy Department, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France., Haesebaert J; Research on Healthcare Performance, INSERM, Université Claude Bernard Lyon 1, Lyon, France.; Pôle de Santé Publique, Service de Recherche et d'Épidémiologie Cliniques, Hospices Civils de Lyon, Lyon, France., Briet C; Department of Endocrinology, Reference Center for Rare Pituitary Diseases, Angers University Hospital, Angers, France.; CarMe team, MITOVASC, CNRS UMR6015, INSERM, U1083, Angers University, Angers, France., Castinetti F; Marseille Medical Genetics, INSERM, UMR1251, Institut MarMaRa, Department of Endocrinology, Reference Center for Rare Pituitary Diseases, Hôpital La Conception APHM, Aix Marseille University, Marseille, France., Cristante J; IRIG Biosanté, INSERM, UMR1292, CEA, CHU Grenoble Alpes, University Grenoble Alpes, Grenoble, France., Drui D; Department of Endocrinology Diabetology and Nutrition, L'institut du Thorax, CHU de Nantes, Nantes University, Nantes, France., Germain N; Department of Endocrinology, Diabetes, Metabolism and Eating Disorders, University Hospital of Saint-Etienne, Saint-Etienne, France.; TAPE Research Group, Eating Disorders, Addictions & Extreme Bodyweight, Jean Monnet University, Saint-Etienne, France., Maione L; Physiologie et Physiopathologie Endocriniennes, INSERM, UMR-S1185, Service d'Endocrinologie et des Maladies de la Reproduction, Hôpital Bicêtre APHP, Université Paris-Saclay, Le Kremlin-Bicêtre, France., Illouz F; Department of Endocrinology, Reference Center for Rare Pituitary Diseases, Angers University Hospital, Angers, France., Sonnet E; Service Diabétologie-Endocrinologie, CHRU Brest, Brest, France., Tauveron I; Service d'Endocrinologie, Diabétologie et Maladies Métaboliques, CHU Clermont-Ferrand, Clermont-Ferrand, France.; Laboratoire GReD, Université Clermont Auvergne, Clermont-Ferrand, France., Merida I; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM, U1028, Université Claude Bernard Lyon 1, Lyon, France.; CERMEP-Life Imaging, Lyon, France., Lancelot S; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM, U1028, Université Claude Bernard Lyon 1, Lyon, France.; CERMEP-Life Imaging, Lyon, France., Costes N; Lyon Neuroscience Research Center, CNRS UMR5292, INSERM, U1028, Université Claude Bernard Lyon 1, Lyon, France.; CERMEP-Life Imaging, Lyon, France., Vasiljevic A; Department of Neuropathology, Hospices Civils de Lyon, Bron, France., Marchand L; Service d'Endocrinologie, Hôpital Saint Joseph Saint Luc, Lyon, France., Rode S; Centre de Consultation de la Sauvegarde, Lyon, France., Bertholon-Gregoire M; Clinique du Renaison, Roanne, France., Criton G; Service de Radiologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Lapras V; Service de Radiologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Cotton F; Service de Radiologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.; Université Claude Bernard Lyon 1, Villeurbann, France.; Laboratoire CREATIS, CNRS UMR5220, INSERM, U1296, INSA Lyon, Villeurbanne, France., Jouanneau E; Skull Base and Pituitary Unit, Department of Neurosurgery B, Neurological Hospital, Lyon, France.; CNRS UMR5286, INSERM, U1052, Cancer Research Center of Lyon, Lyon, France., Bournaud C; Nuclear Medicine Department, Hospices Civils de Lyon, Lyon, France.; Service d'Endocrinologie, Centre Hospitalier de Roanne, Roanne, France; and., Raverot G; Université Claude Bernard Lyon 1, Villeurbann, France.; CNRS UMR5286, INSERM, U1052, Cancer Research Center of Lyon, Lyon, France.; Endocrinology Department, Reference Center for Rare Pituitary Diseases, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 Oct 01; Vol. 66 (10), pp. 1575-1580. Date of Electronic Publication: 2025 Oct 01.
Publication Type: Journal Article; Multicenter Study; Comparative Study; Clinical Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.124.269392